Rogelio Braceras

Attainment of glycaemic goals in type 2 diabetes with once‐, twice‐, or thrice‐daily dosing with biphasic insulin aspart 70/30 (The 1‐2‐3 study)

A. J. Garber, Jack Wahlen, Tyler S. Wahl et al. · Diabetes Obesity and Metabolism · 2005 · 261 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Genomic and biochemical approaches in the discovery of mechanisms for selective neuronal vulnerability to oxidative stress

Xinkun Wang, Asma Zaidi, Ranu Pal et al. · BMC Neuroscience · 2009 · 86 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

Comparison of vildagliptin and thiazolidinedione as add‐on therapy in patients inadequately controlled with metformin: results of the GALIANT trial – a primary care, type 2 diabetes study

Lawrence Blonde, Samuel Dagogo-Jack, Mary Ann Banerji et al. · Diabetes Obesity and Metabolism · 2009 · 49 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Repeated administration of piribedil induces less dyskinesia than <scp>L</scp>‐dopa in MPTP‐treated common marmosets: A behavioural and biochemical investigation

Lance A. Smith, Banu Cahide Tel, Michael Jackson et al. · Movement Disorders · 2002 · 48 citations

Medicine, Neuroscience, Pharmacology +17

Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts)

P. Raskin, Glenn Matfin, Sherwyn Schwartz et al. · Diabetes Obesity and Metabolism · 2007 · 37 citations

Medicine, Pharmacology, Pharmacotherapy +17